Avidity Science Expands Biomedical Research Solutions Through Acquisition of UMG, Inc.
WATERFORD, Wis., Aug. 3, 2021 /PRNewswire/ --Today, Avidity Science announces another significant step in expanding its global leadership in biomedical research solutions via the acquisition of UMG, Inc.
- WATERFORD, Wis., Aug. 3, 2021 /PRNewswire/ --Today, Avidity Science announces another significant step in expanding its global leadership in biomedical research solutions via the acquisition of UMG, Inc.
- This investment expands Avidity's Radio Frequency Identification (RFID) solutions, enhancing its support of the global biomedical research community.
- "We are excited about this investment as it adds unique design, engineering and manufacturing capacity of RFID transponders and readers used in research model identification," said Doug Lohse, chief executive officer, Avidity Science.
- Avidity Science is a worldwide leader in water purification and delivery, control and monitoring and service solutions for the life science and biomedical research communities.